References
- 1. Nischwitz S, Muller-Myhsok B, Weber F. Risk conferring genes in multiple sclerosis. FEBS Lett. 2011; 585 (23): 3789-97.10.1016/j.febslet.2011.03.03721439284
- 2. Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, Moutsianas L, et al. The International Multiple Sclerosis Genetics Consortium (IMSGC), Wellcome Trust Case Control Consortium 2 (WTCCC2). Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011; 476 (7359): 214-9.10.1038/nature10251318253121833088
- 3. Zhang Q, Lin CY, Dong Q, Wang J, Wang W. Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies. Autoimmun Rev. 2011; 10 (8): 474-81.10.1016/j.autrev.2011.03.00321440682
- 4. Faitar SL, Sossey-Alaoui K, Ranalli TA, Cowell JK. EVI5 protein associates with the INCENP-aurora B kinase-survivin chromosomal passenger complex and is involved in the completion of cytokinesis. Exp Cell Res. 2006;312 (12): 2325-35.10.1016/j.yexcr.2006.03.03216764853
- 5. Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, et al. Multiple sclerosis susceptibilitygenes: associations with relapse severity and recovery. PLoS One. 2013; 8 (10): e75416. 10.1371/journal.pone.0075416379399124130709
- 6. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S et al. Multiple sclerosis severityscore: using disability and disease duration to rate disease severity. Neurology. 2005; 64 (7): 1144-51. 10.1212/01.WNL.0000156155.19270.F815824338
- 7. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33 (11) :1444-52.10.1212/WNL.33.11.14446685237
- 8. Čierny D, Hanyšova S, Michalik J, Kantorova E, Kurča E, Škereňova M, Lehotsky J. Genetic variants in interleukin 7 receptor chain (IL-7Ra) are associated with multiple sclerosis risk and disability progression in Central European Slovak population. J Neuroimmunol. 2015; 282: 80-4.10.1016/j.jneuroim.2015.03.01025903732
- 9. Čierny D, Michalik J, Kurča E, Dobrota D, Lehotsky J. FokI vitamin D receptor gene polymorphism in association with multiple sclerosis risk and disability progression in Slovaks. Neurol Res. 2015; 37 (4): 301-8.10.1179/1743132814Y.000000045925376135
- 10. Alexoudi A, Zachaki S, Stavropoulou C, Gavrili S, Spiliopoulou C, Papadodima S et al. Possible Implication of GSTP1 and NQO1 Polymorphisms on Natalizumab Response in Multiple Sclerosis. Ann Clin Lab Sci. 2016; 46 (6): 586-591.
- 11. Mann CL, Davies MB, Boggild MD, Alldersea J, Fryer AA, Jones PW et al. Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurology. 2000; 54(3): 552-7.10.1212/WNL.54.3.552
- 12. Živković M, Životić I, Dinčić E, Stojković L, Vojinović S, Stanković A. The glutathione S-transferase T1 deletion is associated with susceptibility to multiple sclerosis. J Neurol Sci. 2013; 334(1-2):6-9.10.1016/j.jns.2013.07.00123932298
- 13. Stavropoulou C, Korakaki D, Rigana H, Voutsinas G, Polyzoi M, Georgakakos VN et al. Glutathione-Stransferase T1 and M1 gene polymorphisms in Greek patients with multiple sclerosis: a pilot study. Eur J Neurol. 2007; 14(5): 572-4.10.1111/j.1468-1331.2006.01678.x17437619
- 14. Bačić Baronica K, Mlinac K, Petlevski R, Ozretić D, Vladić A, Kalanj-Bognar S, Zuntar I. Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway. Acta Neurobiol Exp (Wars). 2014; 74(3): 257-65.
- 15. Hafler DA et al., INTERNATIONAL MULTIPLE SCLEROSIS GENETICS CONSORTIUM 1. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007; 2007357 (9): 851-62.
- 16. Hoppenbrouwers IA, Aulchenko YS, Ebers GC, Ramagopalan SV, Oostra BA, Van Duijn CM, Hintzen RQ. EVI5 is a risk gene for multiple sclerosis. Genes Immun. 2008; 9 (4): 334-7.10.1038/gene.2008.2218401352
- 17. Johnson BA, Wang J, Taylor EM, Caillier SJ, Herbert J, Khan OA et al. Multiple sclerosis susceptibility alleles in African Americans. Genes Immun. 2010; 11 (4): 343-50.10.1038/gene.2009.81288021719865102